Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,643,418
+$1,328,698 QoQ
Shares Held
8,040
-11.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#1,280
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2020CallValue
$29,604,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SPHERA FUNDS MANAGEMENT LTD. holds $104,911,681 across 12 Drug Manufacturers - General names. LLY ranks #4 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
96,626 | $20,877,013 | |
| 2 | AZN |
Astrazeneca PLC
|
62,530 | $11,856,938 | |
| 3 | SNY |
Sanofi
|
269,515 | $11,497,509 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
8,040 | $9,643,418 | |
| 5 | NVS |
Novartis AG
|
50,000 | $7,836,000 | |
| 6 | ABBV |
AbbVie Inc.
|
30,256 | $7,613,619 | |
| 7 | MRK |
Merck & Co., Inc.
|
58,600 | $7,530,100 | |
| 8 | JNJ |
Johnson & Johnson
|
28,831 | $7,322,209 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,643,418 | 8,040 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,314,720 | 9,040 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,715,108 | 9,040 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,660,520 | 10,040 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,995,776 | 11,540 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,654,887 | 11,690 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,182,680 | 13,190 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,685,548 | 13,190 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,941,962 | 13,190 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,039,252 | 14,190 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,271,634 | 14,190 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $7,621,874 | 14,190 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,358,296 | 15,690 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,882,979 | 31,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,398,429 | 25,690 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $46,416,892 | 143,550 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,879,417 | 132,250 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,130,379 | 70,295 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $44,110,952 | 159,695 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $80,519,769 | 348,495 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,748,540 | 181,895 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $80,183,144 | 429,200 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $69,224,400 | 410,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $23,091,120 | 156,000 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $29,604,000 | 200,000 | Call | Defined | 2020-11-12 | |
| 2020-06-30 | $14,776,200 | 90,000 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||